Therapeutic Potential of Multifunctional Tacrine Analogues

Curr Neuropharmacol. 2019;17(5):472-490. doi: 10.2174/1570159X16666180412091908.

Abstract

Tacrine is a potent inhibitor of cholinesterases (acetylcholinesterase and butyrylcholinesterase) that shows limiting clinical application by liver toxicity. In spite of this, analogues of tacrine are considered as a model inhibitor of cholinesterases in the therapy of Alzheimer's disease. The interest in these compounds is mainly related to a high variety of their structure and biological properties. In the present review, we have described the role of cholinergic transmission and treatment strategies in Alzheimer's disease as well as the synthesis and biological activity of several recently developed classes of multifunctional tacrine analogues and hybrids, which consist of a new paradigm to treat Alzheimer's disease. We have also reported potential of these analogues in the treatment of Alzheimer's diseases in various experimental systems.

Keywords: Alzheimer’s disease; Multifunctional tacrine analogues; cholinergic transmission; hepatoprotection; neuroprotective activity; tacrine hybrids..

Publication types

  • Review

MeSH terms

  • Acetylcholinesterase / metabolism
  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / enzymology
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / pathology
  • Amyloid beta-Peptides / metabolism
  • Animals
  • Butyrylcholinesterase / metabolism
  • Cholinergic Neurons / drug effects
  • Cholinergic Neurons / metabolism
  • Cholinergic Neurons / pathology
  • Cholinesterase Inhibitors / chemistry
  • Cholinesterase Inhibitors / pharmacology*
  • Cholinesterase Inhibitors / therapeutic use
  • Humans
  • Tacrine / analogs & derivatives*
  • Tacrine / pharmacology
  • Tacrine / therapeutic use

Substances

  • Amyloid beta-Peptides
  • Cholinesterase Inhibitors
  • Tacrine
  • Acetylcholinesterase
  • Butyrylcholinesterase